CHRS EPS Estimates
Coherus Oncology, Inc.
$1.05
-$0.02(-1.87%)
44
Overall
80
Value
18
Tech
34
Quality
Market Cap
$162.23M
Volume
1.72M
52W Range
$0.97 - $2.62
Target Price
$7.75
CHRS EPS estimates: the consensus estimate for Coherus Oncology, Inc.'s current fiscal year is -$0.88 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CHRS EPS Estimates
- EPS estimate, current quarter
- $-0.22
- EPS estimate, next quarter
- $-0.21
- EPS estimate, current year
- $-0.88
- EPS estimate, next year
- $-0.85
- EPS growth, 3-year
- +33.52%
| Fiscal year | EPS |
|---|---|
| 2025 | $1.43 |
| 2024 | $0.25 |
| 2023 | $-2.53 |
| 2022 | $-3.76 |
| 2021 | $-3.81 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CHRS | $1.05 | -1.9% | 1.72M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |